---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-005890"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2025-09-12T23:59:59+00:00"
generated_at: "2026-05-17T06:44:06.873300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology grants 124,959 RSUs to CEO and 97,000 RSUs to Interim CFO

## Summary
- CEO Raymond F. Vennare receives 124,959 RSUs; Interim CFO Josh Blacher receives 97,000 RSUs.
- RSUs vest fully on October 31, 2025, subject to continued service through that date.
- Grants made under the 2024 Equity Incentive Plan; form of award agreement filed as Exhibit 10.1.
- Each RSU represents the right to receive one share of common stock upon vesting.

## SEC filing metadata
- accession: 0001171843-25-005890
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2025-09-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184325005890/0001171843-25-005890-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184325005890/f8k_090925.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-005890
- JSON: https://secwatch.observer/filing/0001171843-25-005890.json
- Plain text: https://secwatch.observer/filing/0001171843-25-005890.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.